{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:12Z","timestamp":1787065332877,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":637,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemotherapeutics, one of the standard treatment options for cancer worldwide, have various adverse effects, including erectile dysfunction (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate erectile function in an animal model after administration of the anticancer agent oxaliplatin (L-OHP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Male Wistar\/ST rats were divided into 2 groups: L-OHP rats (n = 21), which were intravenously administered L-OHP (4 mg\/kg; twice a week for 4 weeks), and Control rats (n = 21), which were injected with the same volume of 5% glucose solution, using the same dosing schedule. At the end of the study period, erectile function was evaluated by measuring intracavernous pressure (ICP) and mean arterial pressure (MAP) after cavernous nerve stimulation (n = 9\u201310). Endothelial function was evaluated with an isometric tension study using corpus cavernosum strips (n = 11). Western blot analysis was used to assess neuronal nitric oxide (nNOS) and endothelial NO synthase (eNOS) protein levels (n = 7). Real-time quantitative polymerase chain reaction (qRT-PCR) was used to assess the expression of inflammation- and oxidative stress-related markers (nicotinamide adenine dinucleotide phosphate oxidase-1, p22phox, interleukin [IL]-6, and nuclear factor-kappa B) (n = 6). Statistical significance was determined using the Student\u2019s t-test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The L-OHP group had a significantly lower ICP:MAP ratio than the control group (P &amp;lt; .05). Compared to the Control group, the L-OHP group exhibited significantly lower responses to ACh and eNOS protein levels and significantly higher inflammatory biomarker levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Translation<\/jats:title>\n                    <jats:p>The results based on this animal model indicate that use of the anticancer agent L-OHP should be considered as a risk factor for ED occurring via reduction of NO bioavailability in humans; our results provide possible treatment strategies for maintaining the erectile function of cancer survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and limitations<\/jats:title>\n                    <jats:p>Our study showed that the anticancer agent L-OHP has the propensity to cause ED in rats. A major limitation of this study is the lack of an established cure for ED associated with L-OHP and the lack of clinical evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>L-OHP causes ED in rats via reduction of NO bioavailability caused by endothelial dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T01:08:14Z","timestamp":1626484094000},"page":"1337-1345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Oxaliplatin, an Anticancer Agent, Causes Erectile Dysfunction in Rats due to Endothelial Dysfunction"],"prefix":"10.1093","volume":"18","author":[{"given":"Tomoya","family":"Kataoka","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University , Mizuho-cho, Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Kawaki","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kito","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hotta","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawade","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University , Mizuho-cho, Mizuho-ku, Nagoya , Japan"},{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University , Mizuho-ku, Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"2023072610144311600_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2023072610144311600_bib0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.prro.2020.07.007","article-title":"Preparing patients for sexual dysfunction after radiation for anorectal cancers: a systematic review","volume":"11","author":"Wallington","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"2023072610144311600_bib0003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jad.2020.07.044","article-title":"The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: a systematic review","volume":"276","author":"Liu","year":"2020","journal-title":"J Affect Disord"},{"key":"2023072610144311600_bib0004","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry","volume":"31","author":"Mols","year":"2013","journal-title":"J Clin Oncol"},{"key":"2023072610144311600_bib0005","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/annonc\/mdx351","article-title":"Late toxicities and clinical outcome at 5\u2009years of the ACCORD 12\/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer","volume":"28","author":"Azria","year":"2017","journal-title":"Ann Oncol"},{"key":"2023072610144311600_bib0006","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"G\u00e9rard","year":"2012","journal-title":"J Clin Oncol"},{"key":"2023072610144311600_bib0007","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"2023072610144311600_bib0008","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4251\/wjgo.v12.i6.604","article-title":"Real-world evidence on adjuvant chemotherapy in older adults with stage II\/III colon cancer","volume":"12","author":"Batra","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"2023072610144311600_bib0009","doi-asserted-by":"crossref","first-page":"e3126","DOI":"10.1590\/1518-8345.2959.3126","article-title":"Acupuncture in adults with chemotherapy-induced peripheral neuropathy: a systematic review","volume":"27","author":"Baviera","year":"2019","journal-title":"Rev Lat Am Enfermagem"},{"key":"2023072610144311600_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"Sakurai","year":"2009","journal-title":"Pain"},{"key":"2023072610144311600_bib0011","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jsxm.2020.04.384","article-title":"High salt intake impairs erectile function in salt-sensitive rats through mineralocorticoid receptor pathway beyond its effect on blood pressure","volume":"17","author":"Kishimoto","year":"2020","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0012","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jphs.2016.02.004","article-title":"Mineralocorticoid receptor stimulation induces urinary storage dysfunction via upregulation of epithelial sodium channel expression in the rat urinary bladder epithelium","volume":"130","author":"Yamamoto","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"2023072610144311600_bib0013","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jsxm.2017.11.001","article-title":"Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats","volume":"14","author":"Kataoka","year":"2017","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ijir.2013.21","article-title":"Limited effect of testosterone treatment for erectile dysfunction caused by high-estrogen levels in rats","volume":"25","author":"Kataoka","year":"2013","journal-title":"Int J Impot Res"},{"key":"2023072610144311600_bib0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/jsm.12447","article-title":"Assessment of androgen replacement therapy for erectile function in rats with type 2 diabetes mellitus by examining nitric oxide-related and inflammatory factors","volume":"11","author":"Kataoka","year":"2014","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0016","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1743-6109.2012.02742.x","article-title":"Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction","volume":"9","author":"Hotta","year":"2012","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jphs.2017.10.001","article-title":"High salt loading induces urinary storage dysfunction via upregulation of epithelial sodium channel alpha in the bladder epithelium in Dahl salt-sensitive rats","volume":"135","author":"Yamamoto","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"2023072610144311600_bib0018","author":"Pharmaceuticals and Medical Devices Agency (PMDA) home page"},{"key":"2023072610144311600_bib0019","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1111\/bph.13646","article-title":"Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice","volume":"173","author":"McQuade","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2023072610144311600_bib0020","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/jsm.12597","article-title":"Intracavernous delivery of stromal vascular fraction restores erectile function through production of angiogenic factors in a mouse model of cavernous nerve injury","volume":"11","author":"Song","year":"2014","journal-title":"J Sex Med"},{"issue":"8","key":"2023072610144311600_bib0021","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1743-6109.2008.00955.x","article-title":"Cavernous nerve injury using rodent animal models","volume":"5","author":"Canguven","year":"2008","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0022","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.juro.2007.09.021","article-title":"Tadalafil increases Akt and extracellular signal-regulated kinase 1\/2 activation, and prevents apoptotic cell death in the penis following denervation","volume":"179","author":"Lysiak","year":"2008","journal-title":"J Urol"},{"key":"2023072610144311600_bib0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-7-8","article-title":"Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats","volume":"7","author":"Mihara","year":"2011","journal-title":"Mol Pain"},{"key":"2023072610144311600_bib0024","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1007\/s12035-018-0920-4","article-title":"Rosmarinic acid mitigates mitochondrial dysfunction and spinal glial activation in oxaliplatin-induced peripheral neuropathy","volume":"55","author":"Areti","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2023072610144311600_bib0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jsxm.2018.07.002","article-title":"The favorable effect of empagliflozin on erectile function in an experimental model of type 2 diabetes","volume":"15","author":"Assaly","year":"2018","journal-title":"J Sex Med"},{"key":"2023072610144311600_bib0026","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ijir.2016.50","article-title":"Penile constitutive nitric oxide synthase expression in rats exposed to unpredictable chronic mild stress: role of inflammation","volume":"29","author":"\u015eahin","year":"2017","journal-title":"Int J Impot Res"},{"key":"2023072610144311600_bib0027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/cjpp-2017-0113","article-title":"TNF-\u03b1 antagonism with etanercept enhances penile NOS expression, cavernosal reactivity, and testosterone levels in aged rats","volume":"96","author":"\u015eahin","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"2023072610144311600_bib0028","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fphys.2017.00760","article-title":"Hypercaloric diet establishes erectile dysfunction in rat: mechanisms underlying the endothelial damage","volume":"8","author":"de Souza","year":"2017","journal-title":"Front Physiol"},{"key":"2023072610144311600_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3293065","article-title":"Potential therapeutic role of dietary supplementation with spirulina platensis on the erectile function of obese rats fed a hypercaloric diet","author":"Diniz","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"2023072610144311600_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.reprotox.2020.05.007","article-title":"Naringin regulates erectile dysfunction by abolition of apoptosis and inflammation through NOS\/cGMP\/PKG signaling pathway on exposure to Bisphenol-A in hypertensive rat model","volume":"95","author":"Akintunde","year":"2020","journal-title":"Reprod Toxicol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521005294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521005294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/18\/8\/1337\/50964734\/jsm_18_8_1337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/18\/8\/1337\/50964734\/jsm_18_8_1337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T06:24:58Z","timestamp":1690352698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/18\/8\/1337\/6956142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.06.004","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2021,8]]},"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin, an Anticancer Agent, Causes Erectile Dysfunction in Rats due to Endothelial Dysfunction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}